
Zealand Pharma A/S ZEAL
Geschäftsbericht 2021
hinzugefügt 23.12.2023
Zealand Pharma A/S Finanzkreislauf 2011-2026 | ZEAL
Finanzkreislauf Jährlich Zealand Pharma A/S
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 9.2 | -650 | - | - | - | - | - | - |
Alle Zahlen in DKK-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 9.2 | -650 | -321 |
Finanzkreislauf anderer Aktien in der Pharmaeinzelhändler
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AbCellera Biologics
ABCL
|
173 | $ 3.56 | - | $ 1.06 B | ||
|
Acorda Therapeutics
ACOR
|
117 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Advaxis
ADXS
|
-143 K | - | -9.65 % | $ 45.9 M | ||
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
AgeX Therapeutics
AGE
|
-8.96 K | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
-1.55 K | - | -0.23 % | $ 916 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Aptorum Group Limited
APM
|
-400 | $ 0.79 | 0.01 % | $ 4.31 M | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
21.2 | $ 6.63 | - | $ 182 M | ||
|
BioCardia
BCDA
|
101 | $ 1.27 | - | $ 26.9 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
Catalyst Biosciences
CBIO
|
71.5 | $ 11.58 | - | $ 1.03 B | ||
|
Cerus Corporation
CERS
|
47 | $ 1.8 | 6.51 % | $ 343 M | ||
|
Anika Therapeutics
ANIK
|
270 | $ 14.36 | - | $ 210 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
AVEO Pharmaceuticals
AVEO
|
-123 | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.15 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
174 | $ 2.64 | - | $ 16.6 M | ||
|
Cardiff Oncology
CRDF
|
294 | $ 1.9 | - | $ 127 M | ||
|
CorMedix
CRMD
|
359 | $ 6.54 | - | $ 471 K |